Cancers Upcoming Events Announce Your Event Here

11–13 October 2018 Melbourne International Joint Breast Congress - ASBD, 4th CoBrCa & BreastSurgANZ

Melbourne, Australia

Melbourne International Breast Congress - held jointly with Australasian Society for Breast Disease (ASBD), 4th World Congress on Controversies in Breast Cancer (CoBrCa) & Breast Surgeons of Australia & New Zealand (BreastSurgANZ) - Melbourne, Australia, October 11-13, 2018. As the main congress in the field of breast diseases in the Asia-Pacific region in 2018, it shouldn’t be missed! It will directly address key issues facing clinicians in their daily practice, including medical oncology, surgery, radiation oncology, pathology, reconstruction, breast imaging, & more. The collaboration will create a multi-faceted congress of interest to all involved in the treatment of breast disease.

http://melbournebreast2018.org/

11–12 October 2018 3rd Annual Biomarkers & Precision Medicine USA Congress

San Diego, USA

The 3rd Annual Biomarkers & Precision Medicine USA Congress is part of Oxford Global’s R&D US Series that features 3 outstanding programmes: our long-running 5th Annual Drug Discovery and Chemistry USA Congress, the 3rd Annual Biomarker & Precision Medicine USA Congress, and fast-emerging Advances in Immuno-Oncology USA Congress.

This event will host over 300 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers

4 Interactive Streams:

  • Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases
  • Personalised Medicine, Companion Diagnostics & Patient Testing. Biomarker Assay Validation and Patient Stratification
  • Innovations in Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies
  • Biomarker in Clinical Development & Clinical Trials. Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing

Free Pre-Congress Live Webinars 2018

Moving Diagnostic Biomarkers from Bench into the Clinic
Hosted by James Snider, CSO and President, Critical Diagnostics & Elizabeth Somers, Director Diagnostics, Morphotek

Register today, for free: https://bit.ly/2HOCyR7

Moving Biomarkers from Bench into the Clinic
Hosted by Xuemei Zhao, Senior Principal Scientist, Merck & Co., Inc & Qing Kang, Senior Scientist, Translational Medicine at Syros Pharmaceuticals

Register today, for free: https://bit.ly/2Kw62VC

Driving Precision Medicine and Advancing Big Data in Drug Development
Hosted by Stefan Scherer, Vice President, Global Head Correlative Science, Novartis

Register today, for free: https://bit.ly/2I3sGGq

For further information about the congress, registration fees and discounts available please contact a.saez@oxfordglobal.co.uk or click here: https://bit.ly/2feqU8H

Alternatively visit our website

https://bit.ly/2rd0SWE

11–12 October 2018 Advances in Immuno-Oncology USA Congress

San Diego, USA

Due to the success of the UK Advances in Immuno-Oncology event, Oxford Global are expanding this event to the USA. The USA Congress is the first of its kind and will feature over 20 presentations from leading heads of the Pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate.

Topic discussion ranges across a variety of therapeutic strategies, from CAR T cell therapies to microbiome in Immuno-Oncology and from assays and modelling in Immuno-Oncology to NK cell-based therapeutics.

Further talks look at approaches to clinical trial design and development and Translational Immuno-Oncology. To enhance the interactivity of the program, we have also introduced discussion opportunities through panels, roundtables and workshops on hot topics in this field.

Key speakers include Vice Presidents, Directors and Executives from leading pharmaceutical industries such as Pfizer and Atreca. The two day congress offers the opportunity to have scientific and business discussions, ensuring valuable networking and interactive sessions.

The conference will bring together over 100 senior industry experts and key opinion leaders in Immuno-Oncology.

For further information about the congress, please contact Danielle Dalby at d.dalby@oxfordglobal.co.uk alternatively download the agenda here >> https://bit.ly/2vrwiwW

Free Pre-Congress Live Webinar

The Role For TNFR2 In The Tumor Microenvironment

Hosted by Russell LaMontagne, Chief Executive Officer, Boston Immune Technologies and Therapeutics Inc

Highlights

  • The role TNFR2 tregs
  • TNFR2 Oncogene
  • Novel TNFR2 antibodies

Why should you attend this webinar?

  • Get an in-depth overview of the RWE landscape in Europe
  • Hear key updates from IMI EMIF
  • Discuss collaboration in this growing area

Register for free today

https://bit.ly/2L0l2LD

11–12 October 2018 5th Annual Drug Discovery USA Congress

San Diego, USA

Join Oxford Global’s 5th Annual Drug Discovery USA Congress taking place on the 11-12 October 2018 in San Diego. Across the two days, over 40 expert speakers will provide you with insights into the latest technological innovations and strategic approaches in drug discovery and drug chemistry.
View Agenda here.

The American biopharmaceutical research sector has been a world leader in the development of new medicines over the past 30 years and it continues to drive biopharmaceutical innovation. Our conference delivers an extensive look across the development process: from drug discovery innovation and strategies to computational chemistry and informatics for drug design.

The conference will feature over 40 presentations from leading heads of the pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate. Topic discussion ranges across the latest validation and optimisation strategies in neuroscience, cardiology and oncology. Further talks look at approaches to phenotypic and genomic drug discovery design, as well as novel approaches to drug design: AI-based design, DNA Encoded Libraries and protein-protein interactions.

Include 4 Streams:

  • Day 1 Stream 1: Drug Discovery Innovation and Strategies
  • Day 2 Stream 1: Phenotypic and Genomic Drug Discovery
  • Day 1 Stream 2: Computational Chemistry and Informatics for Drug Discovery
  • Day 2 Stream 2:
    • Part 1: Novel Approaches to Drug Design
    • Part 2: DNA Encoded Libraries
For more information contact g.alonso@oxfordglobal.co.uk or join the congress conversation on Twitter @DrugDiscoveryUS  or our LinkedIn Group: Drug Discovery & Development Network

https://www.oxfordglobal.co.uk/discoveryusa-congress/

Back to Top